Exploring Clinical Trial Endpoints in FSGS: Spotlight on Proteinuria
Exploring the Mechanism of Sparsentan in IgAN: Including a Spotlight on Urinary sCD163, a Key Marker of Inflammation
ASN 2024 Spotlight: New Treatment Targets in IgA Nephropathy
Exploring Clinical Trial Endpoints in FSGS: Spotlight on Proteinuria
Exploring the Mechanism of Sparsentan in IgAN: Including a Spotlight on Urinary sCD163, a Key Marker of Inflammation
ASN 2024 Spotlight: New Treatment Targets in IgA Nephropathy